Angle Leads Reid 50-47 in Nevada After Reid’s Abortion Coverup in Debate

State   |   Steven Ertelt   |   Oct 18, 2010   |   9:00AM   |   WASHINGTON, DC

Angle Leads Reid 50-47 in Nevada After Reid’s Abortion Coverup in Debate

by Steven Ertelt Editor
October 18
, 2010

Washington, DC ( — After Senate Majority Leader Harry Reid did his best during their debate to cover up the abortion funding in the ObamaCare health care reform bill he shepherded through the Senate, a new Rasmussen Reports poll out today shows pro-life candidate Sharron Angle leading 50-47.

The survey of likely voters in Nevada finds Angle with 50% to Reid’s 47% — and another 2% prefer another candidate in the race, and one percent are undecided.

"A week ago, Angle held an insignificant 49% to 48% lead in a contest that has been marked for months by its closeness. In seven of eight surveys prior to this one since July, Reid and Angle have been three points apart or less. Both have hit the 50% mark one time," Rasmussen noted.

The survey of 750 likely Nevada voters was conducted on Sunday and the race is considered a tossup because the three point lead is within the four percent margin of error.

The new poll comes after the debate last week between Reid and Angle, which saw the top Senate Democrat falsely saying the Hyde amendment is preserved by the legislation.

The candidates received a question asking whether they favored having the federal government fund abortions under the new health care reform law.

Angle gave a clear response, "No."

Reid, on the other hand, attempted to convey to voters the erroneous notion that the bill contained sufficient abortion funding limits. He implied the Hyde Amendment is either contained in the legislation or somehow applies to it — neither of which is the case.

"Well, we passed — maintained — Hyde, Hyde Amendment," he stammered.

The moderator of the debate couldn’t decipher the answer as a direct response to his question, saying, "That would be a yes or no?"

Reid paused and responded: "Uh, under the law, eh, that exists today, the Hyde amendment, which has been the law in this country for 30 years, is still there."

Connie Hair, a writer at Human Events, says Reid deceived Nevada voters with the answer, because the Hyde amendment preventing abortion funding with tax dollars is nowhere in the ObamaCare bill, which allows abortion funding in a number of circumstances.

"The Hyde Amendment is part of the annual Department of Health and Human Services budget barring federal funding for abortion through budget outlays," she explained. "It must be renewed each year. The amendment does not bar federal funding of abortion through Obamacare insurance exchanges."

Angle picked up endorsements from National Right to Life and the pro-life Susan B. Anthony List pro-life groups after she won the Republican primary and Nevada Right to Life backed her as well.

“The State of Nevada is fortunate to have a champion of the unborn running for United States Senate against Harry Reid,” Jeremy McNeil, director of its PAC, told “While a state legislator, Sharron Angle consistently voted according to her pro-life convictions and sponsored significant pro-life legislation.”

“Sharron Angle and Harry Reid stand in stark contrast on the issue of abortion. While Harry Reid asserts he is pro-life, his actions belie his words,” McNeil said. “Reid has helped spearhead the Obama Administration’s radically pro-abortion agenda, including blocking an amendment to prevent the federal government from subsidizing health plans that cover abortion on demand and voting to fund the U.N. Population Fund, which has significant ties to government-coerced abortions in China.”

Related web sites:
Nevada Right to Life –


Sign Up for Free Pro-Life News From

Daily Pro-Life News Report Twice-Weekly Pro-Life
News Report
Receive a free daily email report from with the latest pro-life news stories on abortion, euthanasia and stem cell research. Sign up here. Receive a free twice-weekly email report with the latest pro-life news headlines on abortion, euthanasia and stem cell research. Sign up here.